Skip to content
ppharmaranks
Menu
Class IIOngoing

Ergocalciferol recall

FDA recall D-0250-2025 · initiated Feb 17, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 12, 2025How we research

Safecor Health, LLC recalled Ergocalciferol in Feb 2025 — an FDA Class II recall (D-0250-2025) because Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Another quality failure

A quality failure that does not fit the categories above.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025

Quantity recalled: 3069 Oral Syringes

Details

Product
Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral Syringe, Delivers: 0.05 mL Oral Solution, Mfg by: Westminster, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: 69367028302.
Recalling company
Safecor Health, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Feb 17, 2025
FDA report date
Mar 12, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ergocalciferol recalled?
Safecor Health, LLC recalled Ergocalciferol in Feb 2025 — an FDA Class II recall (D-0250-2025) because Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Ergocalciferol recalled?
Per the FDA enforcement record, the reason for recall D-0250-2025 was: Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Is a recalled Ergocalciferol dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ergocalciferol are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot #: 24300812, Exp 01/31/2025; 24530836, Exp 07/19/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0250-2025.

Source: openFDA Drug Enforcement record D-0250-2025

← All drug recalls